Metabolite results when a drug is metabolized into a modified form which continues to produce effects. Endogenous variables like age, sex, body composition, genetics, and underlying pathologies have an impact on a given body fluid's metabolome. The activity of an enormous variety of enzymes and transporters responsible for the production, transformation, degradation, and compartmentalization of these small molecules typically keeps the levels of the enormous variety of unique small-molecule metabolites tightly regulated. In the brain, endogenous small molecules are typically present at levels that are tightly controlled.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V106828 | (S)-(-)-2-Methylbutanol | 1565-80-6 | S)-(-)-2-Methylbutanol is the S isomer of 2-methylbutanol. |
|
V72318 | (S)-(-)-Phenylethanol | 1445-91-6 | (S)-(-)-Phenylethanol is an endogenously produced metabolite. |
|
V72616 | (S)-2-acetamido-4-amino-4-oxobutanoic acid | 4033-40-3 | (S)-2-acetamido-4-amino-4-oxobutanoic acid is an endogenously produced metabolite. |
|
V72620 | (S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid dihydrate | 18835-59-1 | (S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid dihydrate is an endogenously produced metabolite. |
|
V120193 | (S)-3,4-Dihydroxybutyric acid sodium | 146838-41-7 | Sodium (S)-3,4-dihydroxybutyrate is a normal human urine metabolite, but its concentration is elevated in the urine of patients with succinate semialdehyde dehydrogenase (SSADH) deficiency. |
|
V105805 | (S)-3-Hydroxyhexanoyl-CoA | 79171-47-4 | (S)-3-Hydroxyhexanoyl-CoA (L-3-Hydroxyhexanoyl-CoA) is a hydroxyacyl-CoA. |
|
V118355 | (S)-5-Hydroxyequol | 276669-86-4 | (S)-5-hydroxyestradiol is a metabolite of soy isoflavones and has antioxidant and anti-inflammatory effects. |
|
V77446 | (S)-Cystathionine-d4 | (S)-Cystathionine-d4 is the deuterium labelled form of (S)-Cystathionine. | |
|
V72806 | (S)-Higenamine ((S)-Norcoclaurine) | 22672-77-1 | (S)-Higenamine ((S)-Norcoclaurine), the S-isomer of Higenamine, is the starting compound for the biosynthesis of benzylisoquinoline alkaloids. |
|
V72663 | (S)-Higenamine hydrobromide ((S)-Norcoclaurine hydrobromide) | 105990-27-0 | (S)-Higenamine ((S)-Norcoclaurine) HBr, the S-isomer of Higenamine, is the starting compound for the biosynthesis of benzylisoquinoline alkaloids. |
|
V77627 | (S)-L-Cystine-15N2 | (S)-L-Cystine-15N2 is L-Cystine labeled with 15N. | |
|
V70971 | (S)-Malic acid-d3 ((S)-Hydroxybutanedioic acid-d3; (S)-E 296-d3) | 59652-74-3 | (S)-Malic acid-d3 is the deuterated form of (S)-Malic acid. |
|
V72744 | (S)-Nornicotine hydrochloride | 101832-65-9 | (S)-Nornicotine (HCl) is an optically active nornicotine compound utilized in study/research of dopamine-related disorders and disease states. |
|
V71095 | (S)-Salsolinol ((-)-Salsolinol) | 27740-96-1 | (S)-Salsolinol ((-)-Salsolinol) is a dopamine-derived endogenously produced metabolite. |
|
V122233 | (S)-β-Aminoisobutyric acid hydrochloride | 925704-45-6 | (S)-β-Aminoisobutyric acid hydrochloride is a cell protectant. It is a non-protein amino acid enantiomer derived from the metabolism of valine in skeletal muscle mitochondria. |
|
V81924 | (S,R,S)-AHPC-Me-C6-NH2 | 2411422-49-4 | (S,R,S)-AHPC-Me-C6-NH2 may be utilized in the preparation /synthesis of PROTAC. |
|
V102021 | (Z)-2-(Oleoyloxy)propane-1,3-diyl dipalmitate | 2190-25-2 | 1,3-Dipalmitoyl-2-oleoylglycerol (1,3-palmitoyl-2-oleoylglycerol; TG(16:0/18:1/16:0)) is a triglyceride containing palmitic acid at the sn-1 and sn-3 positions and oleic acid at the sn-2 position. |
|
V81903 | (Z)-2-Octenoic acid | 1577-96-4 | Z-2-Octenoic acid is the Z-isomer of 2-Octenoic acid. |
|
V82012 | (Z)-4-Amino-4-oxobut-2-enoic acid | 557-24-4 | (Z)-4-Amino-4-oxobut-2-enoic acid is an endogenously produced metabolite. |
|
V101945 | (Z)-9-Heptadecenoic Acid | 1981-50-6 | (Z)-9-Heptadecenoic acid (C17:1(9Z); Margaroleic acid) is a monounsaturated fatty acid and the main component of ruminant fat and milk. |